Avraham Pharmaceuticals Ltd.
๐ฎ๐ฑIsrael
- Country
- ๐ฎ๐ฑIsrael
- Ownership
- Holding
- Established
- 2010-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.avphar.com
A 3 Year Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive Impairment
Phase 2
Completed
- Conditions
- Mild Cognitive ImpairmentDementia
- Interventions
- Drug: Placebo
- First Posted Date
- 2011-09-07
- Last Posted Date
- 2017-06-15
- Lead Sponsor
- Avraham Pharmaceuticals Ltd
- Target Recruit Count
- 210
- Registration Number
- NCT01429623
- Locations
- ๐ฎ๐ฑ
Memory Clinic, Sheba Medical Center at Tel Hashomer, Ramat Gan, Israel
๐ฉ๐ชOtto-von-Guericke-Universitat, Universitatsklinik fur Neurologie und fur Stereotaktische, Magdeburg, Germany
๐ฆ๐นPrivatordination Rainer, Wien, Austria
Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease
Phase 2
Completed
- Conditions
- Alzheimer's DiseaseDementiaMemory LossCognitive Impairment
- Interventions
- First Posted Date
- 2011-05-17
- Last Posted Date
- 2020-07-30
- Lead Sponsor
- Avraham Pharmaceuticals Ltd
- Target Recruit Count
- 200
- Registration Number
- NCT01354691
- Locations
- ๐ญ๐ท
Clinical Hospital Dubrava, Avenija Gojka Suska 6, Zagreb, Croatia
๐ฉ๐ชKlinische Forschung Hamburg GmbH, Hoheluftaussee 18, Hamburg, Germany
๐ช๐ธCentro Geroinnova Barcelona, Calle Mandoni n 17, Barcelona, Spain
ยฉ Copyright 2025. All Rights Reserved by MedPath